In vitro superfusion method for the investigation of nerve-immune cell interaction in murine spleen.
Immune defence mechanisms can be modulated by brain function. To study such interactions, an in vitro method was developed to examine the release of cytokines and norepinephrine (NE) after electrical stimulation. Slices of mouse spleen were placed in chambers with a volume of 80 microliters and superfused with culture medium. To characterize electrically evoked NE release and cell viability a suitable stimulation protocol was developed using of [3H]NE. As parameter for immune function, modulation of interleukin-6 (IL-6) release by the spleen cells brought about by electrical stimulation was investigated. Splenic [3H]NE overflow was calcium-dependent, tetrodotoxin-sensitive and elicited by 54 mM potassium. Electrically evoked [3H]NE release at 22 h was about 80% of the release at 5.3 h. Electrical stimulation substantially reduced IL-6 secretion at 6 h (control: 143.4 +/- 14.3 vs. electrical: 71.3 +/- 7.9 pg/ml/10(6) leukocytes, P = 0.0001). This effect was inhibited in a concentration-dependent manner by the beta-adrenergic antagonist propranolol (P = 0.0298, EC50 approx. 10(-7) M). In conclusion, this new technique allows long-term investigation of cell function in slices of murine spleen. In addition, these are the first in vitro data indicating the presence of a functional neuroimmunological link in murine lymphoid tissue.
Straub
R H
RH
Department of Internal Medicine I, University Hospital, Regensburg, Germany.
Lang
B
B
Falk
W
W
Schölmerich
J
J
Singer
E A
EA
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002470:Cell Survival; D002478:Cells, Cultured; D004558:Electric Stimulation; D005260:Female; D066298:In Vitro Techniques; D015850:Interleukin-6 / Q000378:metabolism*; D008564:Membrane Potentials / Q000187:drug effects; D051379:Mice; D008815:Mice, Inbred Strains; D009638:Norepinephrine / Q000378:metabolism*; D010477:Perfusion; D011188:Potassium / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D026941:Sodium Channel Blockers; D013154:Spleen / Q000276:immunology* / Q000294:innervation*; D013779:Tetrodotoxin / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D015850:Interleukin-6; D026941:Sodium Channel Blockers; D014409:Tumor Necrosis Factor-alpha; D013779:Tetrodotoxin; D011433:Propranolol; D011188:Potassium; D002118:Calcium; D009638:Norepinephrine